A series of 50 gastric endocrine tumors classified according to Rind et al.
[1] comprised 12 small cell neuroendocrine carcinomas (NEC) and 38 ECL cel
l carcinoids, of which 22 associated with type A chronic atrophic gastritis
(A-CAG), eight with hypertrophic gastropathy due to combined Multiple Endo
crine Neoplasia and Zollinger/Ellison syndrome (MEN/ZES), and eight sporadi
c. Variables found to predict tumor malignancy were: size >2 cm, >2 mitoses
and >130 Ki67 positive cells/ 10 high power fields (HPF), grade 2 or 3 his
tology, angioinvasion, p53 protein nuclear accumulation, and the presence o
f a single tumor. None of these factors increased significantly the predict
ing ability of tumor classification itself, although grade 2+3 shows 100 pe
rcent negative predictive value and Ki67 and angioinvasion 100 percent posi
tive predictive value. When the mostly non-malignant A-GAG and MEN-ZES tumo
rs were analysed against the mostly malignant sporadic acid NEC tumors, a p
ositive predictive value of 90 percent and a negative predictive value of 9
3 percent was obtained. Investigation of a larger tumor series is under way
with the aim to develop an optimal model for prognostic evaluation of gast
ric endocrine tumors.